Alefacept Completed Phase 4 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00655564Long-Term One Year Use of Alefacept (AmeviveĀ®) in Moderate to Severe Chronic Plaque Type Psoriasis